share_log

HC Wainwright & Co. Initiates Coverage On ImmunoPrecise Antibodies With Buy Rating, Announces Price Target of $9

HC Wainwright & Co. Initiates Coverage On ImmunoPrecise Antibodies With Buy Rating, Announces Price Target of $9

HC 溫賴特 & 有限公司.起始覆蓋免疫抗體與買入評級, 宣布價格目標 $9
Benzinga Real-time News ·  2022/12/02 06:34

HC Wainwright & Co. analyst Swayampakula Ramakanth initiates coverage on ImmunoPrecise Antibodies (NASDAQ:IPA) with a Buy rating and announces Price Target of $9.

HC 溫賴特 & 有限公司. 分析師斯瓦揚帕庫拉拉拉馬坎啟動對免疫抗體覆蓋 (NASDAQ: IPA) 與買入評級,並宣布目標價格為 $9.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論